J&J | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.18B 349M 2025-03
Abbott USD 6.95B 419M 2025-06
Amgen USD 8.03B 782M 2025-06
AstraZeneca USD 7.06B 1.83B 2025-06
Baxter International USD 2.29B 530M 2025-03
Bayer EUR 4.56B 542M 2025-06
Becton, Dickinson and Co. USD 735M 68M 2025-06
Biogen USD 2.76B 160.5M 2025-06
Boston Scientific USD 725M 311M 2025-03
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
CONMED USD 33.93M 1.55M 2025-06
Cooper Companies USD 116.2M 15.3M 2025-04
Dexcom USD 1.16B 254.1M 2025-06
Edwards Lifesciences USD 3.14B 95.4M 2025-03
Eli Lilly USD 3.38B 282.6M 2025-06
Gilead Sciences USD 5.14B 2.78B 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
Globus Medical USD 229.45M 231.82M 2025-06
Hologic USD 1.74B 305.7M 2025-06
Insulet USD 1.12B 107M 2025-06
Integra LifeSciences USD 217.91M 21.19M 2025-06
Intuitive Surgical USD 9.53B 431.3M 2025-06
J&J USD 38.47B 32.35B 2025-03
Medtronic USD 2.22B 978M 2025-04
Merck USD 8.01B 622M 2025-06
Merit Medical Systems USD 341.82M 53.71M 2025-06
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.64B 208M 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 15.36B 7.37B 2025-06
Stryker USD 2.38B 55M 2025-06
Tandem Diabetes Care USD 64.11M 10.54M 2025-06
Teva Pharmaceutical Industries USD 2.16B 464M 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06
Zimmer Biomet Holdings USD 556.9M 827.6M 2025-06
Zoetis USD 1.44B 286M 2025-06


J&J Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.